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Abstract 
 
 
Perforating branches of the middle cerebral artery, namely the striato-lenticular 
arteries provide the majority of blood supply for the striatum and posterior limb of the 
internal capsules. Occlusions of these arteries cause a small stroke but have a 
devastating effect on patients’ functions. Previous studies showed that the anterior 
two thirds of the internal capsule is occupied by the prefrontal tracts with the 
posterior one third by connection to/from sensorimotor, temporal and posterior 
parietal cortices. In this study, we aimed to examine the long-term effect of infarction 
in the striato-capsular region on cerebral cortex thickness and also its association 
with stroke volume and different functional tests. We hypothesized that because of 
extensive connections of striatum and internal capsule with the cerebral cortex, 
infarction of this area results in an extensive cortical thickness degeneration which 
could in turn cause low fictional measurement scores. 
 
High resolution T1 weighted MRI was obtained from 21 patients with ischemic stroke 
in the striatum/posterior limb of the internal capsule region. Subjects were carefully 
selected from a pool of 140 stroke cases recruited for the Northstar Stroke Project. 
63 healthy volunteers (30 male), matched for age and gender were also chosen to 
form the control group from the OASIS database. Patients and normal subjects were 
right handed except for 3 patients who have the stroke in the left side of the brain. 
Patients were defined as left-sided stroke and right-sided stroke depending on the 
side of the stroke in brain. MRI scans were done 6 months to 2 years after the 
stroke. To measure cortical thickness, we used Freesurfer software. Vertexwise 
group comparison was carried out using General Linear Models (GLM). With the 
Significance level set at 0.05. 
 
Population maps of stroke lesions showed that the majority of strokes were located 
in the striatum and posterior internal capsule. Cortical thickness reduction was 
greater in the ipsilateral hemisphere. Vertex-wise group comparison between left-
sided stroke patients and controls group showed significant reduction in the cortical 
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thickness in the dorsal and medial prefrontal, premotor, posterior parietal, 
precuneus, and temporal cortex which survived after correction for multiple 
comparison using false discovery rate at Freesurfer. Similar comparison for right-
sided stroke showed a similar pattern of cortical thinning, however the extent of 
cortical thinning was much less than in that of the left-sided stroke patients but the 
ROI analysis showed the main effect of side was significant (f (1, 19) =6.909, 
p=0.017), which showed that the left hemisphere stroke side group had a thicker 
cortex (mean=2.463, sd= 0.020)  on average compare to the right hemisphere stroke 
side (mean=2.372, sd= 0.028). Primary motor cortex was surprisingly spared in both 
stroke groups. In addition,  volume of the corpus callosum increased significantly in 
the stroke group. 
The differences between motor cortex (M1) thickness in left-hemispheric stroke 
patients versus controls (t=1.24, n=14, p>0.05) and right-hemispheric stroke patients 
versus controls (t=-0.511, n=7, p>0.05) were not significant. There was a negative 
correlation between the volume of the stroke lesions and the affected M1 thickness. 
There was no correlation between the stroke volume and functional tests in patients 
and also no correlation between the motor cortex thickness and functional tests in 
patients. Regarding normal subjects, comparison between two sides of the brain 
showed that the both hemispheres are symmetrical. In addition, correlation between 
age and cortical thickness showed a negative significant correlation (1-tailed, 
p<0.0007, manual correction for multiple comparisons) in M1, superior frontal, lingual 
cortex at both side of the brain and also negative significant correlation in superior 
temporal cortex and isthmus cingulated cortex on the left side of brain and 
supramarginal cortex on the right side of brain but there was no significant difference 
in cortical thickness between males and females. 
 
The finding from this study suggests that the size of the lesion can be a predictor of 
further M1 cortex reduction. The correlation of M1 thickness with stroke volume 
showed that secondary cortical degeneration may be mainly depends on the size of 
neuronal loss in strital-capsular stroke. 
From normal subject study it can be concluded that generally cortical thickness will 
decrease with ageing but gender does not have an effect on the cortical thickness. 
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Furthermore, the lack of behavioural correlation with M1 thickness and stroke 
volume and also the non significant M1 cortex reduction versus control group may 
suggest that the long-term functional disability after capsular-striatal stroke may not 
be entirely dependent on primary motor cortex and secondary motor cortex and 
primary somatosensory cortex could have an important role as well. These results 
may help to understand why relatively small subcortical infarcts often cause severe 
disability that is relatively resistant to recovery in the long term. 
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Chapter 1 – Introduction  
 
 
Introduction 
 
This aim of this study is to explore the long-term effect of a focal chronic 
stroke (straital-capsular stroke) on the structure of cortical and subcortical 
regions of the brain as measured by cortical thickness and volume. The 
hypothesis of this study is that striato-capsular stroke has an effect on the 
cortical thickness which could reduce functional measurement scores in the 
tests related to assess the impairment after stroke. 
 
Stroke is the second most common cause of death in the world after heart 
disease and cancer and the leading cause of long-term disability [1-3]. In the 
United States, about 750,000 strokes and 150,000 resulting deaths occur 
annually [1]. The Stroke Association estimated that 150,000 people have a 
stroke in the UK each year and also there are over 67,000 deaths due to 
stroke in the UK and approximately 300.000 people in England living with 
moderate to severe disabilities as a result of stroke [4, 5]. Stroke costs around 
£7 billion per annum for England and Wales [6] . In fact the direct cost to the 
NHS is about £2.8 billion a year which is more than the cost of treating 
coronary heart disease [5]. 
 
The common subtypes of stroke are atherothrombotic, cardioembolic, lacunar 
and hemorrhagic[1]. As the study sets to explore the effect of lacunar stroke 
on the structure of cortical and subcortical regions, the following debate is 
focused on lacunar stroke. 
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The lacunar infarcts or small subcortical infarcts result from occlusion at a 
single penetrating artery (size between 2-17 mm) and optionally they are 
based in the internal capsule and basal ganglia [7]. Hence striatal-capsular 
stroke is a lacunar stroke with the infarction in striatum and internal capsule. 
Lacunar infarcts account for one quarter of cerebral infarctions [8]. From 
radiological diagnosis of cerebral infarction, 32.7% were lacunar infarcts [3], 
more than other types of cerebral infarctions. On the other hand, because of 
the difficulties in imaging of small arteries, informative imaging studies are 
scarce. Also, because of the lower rate of mortality evidence from direct 
pathological studies is limited [9]. Hypertension and diabetes mellitus are 
major risk factors for lacunar stroke [10]. 
 
Lacunar infarcts show a paradoxical clinical course with favourable results in 
the short term, a low early mortality and reduced functional disability on 
hospital discharge, but in the mid- and long term are characterized by 
increasing risk of death, stroke recurrence and dementia [8, 11, 12]. Therefore 
it should be considered as a potentially severe condition [8].  
 
 
Depending on the lesion site, signs and symptoms are different. Symptoms 
are loss of sensation, movement impairment and speech, sight, balance and 
coordination difficulties [13]. Hemiparesis with or without ipsilesional 
hemisensory loss is the most common symptom for lacunar stroke which is 
involving the blood supply of the striatum and internal capsule [13] [1].  
Lesions in the brain stem can also produce hemiplegia [1]. Weakness 
affecting the face and arm more than the leg suggests a stroke in the middle 
cerebral artery territory, whereas a deficit mainly involving the legs is 
characteristic of an anterior cerebral artery lesion [1].  
 
The most important etiologies of stroke in the anterior circulation are internal 
carotid artery stenosis, cardiac embolism and atherothrombotic disease of the 
major intracranial branches [1, 14] and small vessel disease of the penetrating 
6 
 
 
 
 
arteries [1]. Even a small stroke in the internal capsule could obviously have 
major consequences. After stroke, prognoses vary considerably among 
patients. 
 
The initial deficit and the degree of motor recovery after ischemic stroke are 
related to such factors as lesion type and size and also the degree of 
Wallerian degeneration (WD) is related to the degree of functional recovery 
[15] . Wallerian degeneration is a process that happens when a nerve fibre is 
crashed or cut, and then the part of axon separated from the neurons cell 
body [16]. 
 
 
 In previous studies it has been shown that impaired upper limb function is due 
to reduced cortical control of spinal neurons and  Wallerian degeneration  of 
the corticofugal tracts (CFT) [17] and the function of CFT is useful  for  
predicting  functional outcome after stroke. There is a correlation between the 
degree of WD in CFT and upper limb function [17]. Therefore based on this 
information this study is going to explore how stiatal-capsular stroke causes 
corticofugal tract degeneration and following that it affects hand impairments.   
 
 
Many studies have clarified and measured motor recovery and neuronal 
plasticity after acute stroke [18, 19] . The recovery varies from a few months to 
years and most of that occurs in the first three months [20] . 
Most understanding of the recovery mechanism is based on animal and 
imaging studies, which highlights the potential of plastic adjustment in cortical 
and subcortical structures under specific training or behavioural adaption [21] . 
 
Several mechanism are considered to be involved in the recovery process 
such as recovery of penumbral tissues, neural plasticity, diaschisis (sudden 
loss of function in a part of brain which is distance of a damaged area but they 
are connected by neurons) and behavioural compensation [22].  
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Reducing the oedema and reperfusion of the ischemic penumbra during the 
acute phase after stroke and following that neuronal rearrangements and 
adaptive responses are the recovery process, which can take many months 
[23]. 
 
It is assumed that the lesion area recovers as a result of tissue repair, while its 
function is controlled by the cortical or subcortical area either next to or remote 
from the damaged area [21, 22]. This mechanism requires understanding of 
re-activation of previous present but functionally inactive neuron connections, 
axonal and dendritic regeneration, synaptogenesis and denervation 
hypersensitivity [22]. This is the base of the Von Monakow theory which is 
known as resolution of diaschisis [21, 24-26]. Resolution diaschisis is 
reactivation of functionally suppressed areas of brain which is connected to 
but at a distance from the damaged area [21] [24]. 
 
Calautti et al 2001. showed that the brain with subcortical infarction has less 
over- activation later than at the early time point of the stroke [27], therefore 
earlier rehabilitation is more useful (discussed in next section). 
 
To explore the effect of brain stroke on the different areas of the brain and 
also the relevant functional impairment, understanding of the anatomy of the 
brain and the circulation system are very important. Hence the anatomy and 
blood circulation of the brain will be explained in the next section. 
 
 
Anatomy of the basal ganglia and internal capsule  
 
The internal capsule is a continuous sheet of fibres that forms the medial 
boundary of lenticular nucleus and then continues around posteriorly and 
inferiorly to partially envelop this nucleus. Inferiorly many of the fibres in the 
internal capsule funnel down into the central peduncle. Superiorly they all fan 
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out into the corona radiata, in which they travel through the centrum semiovale 
to reach their cortical origins or destinations [28]. 
 
The lentiform nucleus (putamen and globus pallidus) is part of the basal 
ganglia which is encapsulated in white matter and the laminae bounding its 
outer and inner surfaces as the external and internal capsule, respectively. 
The internal capsule is limited laterally by the lentiform nucleus and medially 
by thalamus as the posterior limb of internal capsule (PLIC) and head of the 
caudate as anterior limb of Internal capsule (ALIC) [29] the GENU (Latin for 
knee) is which joins the two limbs [28]. 
 
The striatum is the input nucleus of the basal ganglia, receiving afferent 
projections from the cerebral cortex. The caudate nucleus, which participates 
in eye movement control and cognition, the putamen, which participates in 
control of limb and trunk movements; and nucleus accumbens, which 
participates in emotions, are the three subnuclei of the striatum [28].There is a 
path from the striatum to two intrinsic nuclei (the external segment of globus 
pallidus and the subthalamic nucleus) which comprises the indirect path of the 
basal ganglia , and inhibits the production of movements [28]. 
 
 
The internal capsule is divided into five regions on the basis of the relationship 
of each part of the lenticular nucleus. The anterior limb is the portion between 
the lenticular nucleus and the head of the caudate nucleus [2, 30] The 
posterior limb is the portion between the lenticular nucleus and the thalamus. 
The genu is the portion at the junction of the anterior and posterior limbs. The 
retrolenticular part and the sublentricular parts are the portions posterior and 
inferior to the lenticular nucleus, respectively [30]. 
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Functional anatomy 
 
Internal capsule and cortical connections 
 
The large collections of thalamocortical and corticothalamic fibres need a 
route by which to travel from their origins to their destinations. This route is 
provided by the internal capsule. Almost all the neural traffic to and from the 
cerebral cortex passes through the internal capsule [30]. 
Fibres project from the cerebral cortex through the internal capsule to various 
parts of the basal ganglia, for example, the putamen and the caudate nucleus. 
All of these fibres fan out as corona radiata just above the internal capsule 
and mingle with other fibre bundles interconnecting different cortical areas in 
the centrum semiovale of each hemisphere [30] . 
 
Prefrontal cortex connections have been located within the anterior limb of 
internal capsule (ALIC) and the anterior part of the posterior limb of internal 
capsule (PLIC) and also the M1 tract is exactly posterior to the premotor 
region and it is followed by the S1 tract. Most pathways of the temporal cortex 
are in the posterior lateral part of the PLIC and the rest are located in the 
medial border of the ALIC. The occipital cortical connection is within the most 
posterior part of the PLIC [31]. 
 
 
Brain blood circulation (internal capsule and striatum) 
 
When the blood supply of the brain is suddenly cut off or reduced, ischemic 
stroke will happen. Depending on which artery has been blocked, ischemic 
stroke will impact on the area which was fed by that particular artery [13]. 
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The principal blood supply for the brain comes from two arterial systems that 
receive blood from different systemic arteries: the anterior circulation (or 
carotid circulation) fed by the internal carotid artery and the posterior 
circulation (vertebral-basilar circulation), which receives blood from the 
vertebral arteries [2].  
 
The middle cerebral artery (MCA) and anterior cerebral artery are the terminal 
branches of the internal carotid artery and the posterior cerebral artery is 
separated from the basilar artery [32]. MCA is the largest branch of the 
internal carotid artery and the cortical area supplied by the middle cerebral 
artery includes the insula, claustrum, and the lateral portion of the hemisphere 
which includes the brain motor areas [29]. Figure 1 shows the arterial supply 
of the cerebral cortex. 
 
 
The anterior cerebral artery encompasses the frontal lobes, basal ganglia, 
internal capsule and a major portion of the temporal lobes[1] and the areas 
which are fed by the posterior or vertebrobasilar artery are the brain stem, 
cerebellum, thalamus, occipital lobes and medial and inferior temporal lobes 
[1]. 
 
The arterial supply of the thalamus, hypothalamus, basal ganglia and internal 
capsule derives from both the anterior and posterior circulation. Different parts 
of the internal capsule are supplied by different principal sources [2]. 
 
 
The superior halves of the anterior and posterior limbs are supplied by 
branches of the middle cerebral artery. The inferior half of the internal capsule 
is supplied by the anterior cerebral  and anterior choroidal arteries [29]. 
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Figure 1: This figure shows parts of brain are supplied by different arteries: figure A is 
the lateral view and Figure B is the medial view of brain. Blue colour: anterior cerebral 
artery, red colour: middle cerebral artery. Green colour: posterior cerebral artery [13]. 
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 Figure 2: The diagram shows the head and neck arteries with the  
main branches. 
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Rehabilitation after stroke 
 
Rehabilitation is an effective process and the most common treatment for 
reducing the impairment and improving the quality of life after stroke [22, 33]. 
Rehabilitation after stroke reduces the relative risk of death by 50% and the 
relative risk of discharge to nursing home by 40% [34].  
Rehabilitation does not just involve training disabled people themselves but 
also their family and community are involved in rehabilitation plans and the 
aim of this process is to help each patient to achieve the highest possible level 
of individual physical and psychological performance [22, 35]. The process of 
rehabilitation is solving a problem in a standard frame of medical practice, 
such as a treatment for a diagnosed disease [33].  
 
Recovery of motor deficit following stroke is a complex and multifunctional 
process [23]. To decrease the rate of impairment early rehabilitation (within 24 
hours) is suggested, which could vary according to patients’ needs including 
speech and language therapy, physiotherapy or clinical psychology treatment 
[36, 37]. Rehabilitation after stroke might happen over weeks and months or it 
can continue for several years after stroke, until maximum recovery is 
achieved, thus it covers the chronic phase of stroke as well [36, 37]. Studies 
have shown that exercising the affected hand, especially hand and wrist 
movement is essential in all levels of the rehabilitation schedule [38], and that 
has been suggested that higher-intensity training results in better functional 
outcome [39]. As rehabilitation is expensive, finding the better approach is an 
important area of research.  
 
To evaluate effectiveness of the rehabilitation after stroke, MRI scans can be 
used to detect structural changes such as changes in the gray matter in cortex 
and also, volume changes in different structures [40]. 
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Neuroimaging studies can provide crucial information regarding tissue injury, 
such as size, location, and degree of reversibility of ischemic injury and also 
the presence of haemorrhage [41]. Computerised tomography (CT) and 
magnetic resonance imaging (MRI) scans are the most non-invasive 
techniques [41]. CT scanning is quicker than MRI (which needs at least 45 
minutes) and the risk to the patients is minimal. On the other hand artefacts 
may occur at bone and soft tissue interfaces [42], in addition CT is insensitive 
to detecting small cortical or subcortical infarctions [41]. 
 
Thus, to diagnose stroke, MRI became the ideal technique for imaging 
patients with suspected acute stroke, detecting both infarction and other 
differential diagnoses [8]. MRI is able to assess three main aspects such as 
parenchyma, perfusion, and penumbra in acute stroke patients [43]. 
 
MRI images are classified according to their signal intensity on T1- and T2-
weighted images [44]. High resolution T1 weighted MRI with improved 
contrast has been used for patients with striato-lenticular stroke more than 6 
months prior to data collection. MRI will be used in this study to measure 
cortical thickness and volume of cerebrum as well as subcortical region 
volume. 
Following the cell body or proximal axon injury, degeneration of axons (distal 
to the injury) and the myelin sheaths occur which is called Wallerian 
Degeneration (WD) [45]. WD happens following several conditions but the 
most common cause is cerebral infarction [46]. 
 
WD happens in both the peripheral nervous system (PNS) and central 
nervous system (CNS). 
 
We hypothesized that because of the extensive connection of the striatum and 
internal capsule with the cerebral cortex, infarction in this area will result in 
significant cortical degeneration and also significant negative changes would 
be expected in functional scores. 
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This study aims to clarify differences related to cortical thickness such as: 
differences in cortical thickness in the affected hemisphere in both left and 
right sided stroke group versus control group, differences in M1 thickness 
between right hemispheric stroke and control group and left hemispheric 
stroke and control group, and also asymmetry in cortical thicknesses in the 
normal subjects. After this particular study further degeneration and following 
impairment might be predictable therefore these images might be helpful in 
future for rehabilitation. 
 
In addition, to explore the importance of the impact of stroke it is necessary to 
look at the body functions and structure, activity, personal and environmental 
factors and participation; as the international classification of the functioning 
model. This will be explained with details in the next chapter. 
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Chapter 2 – Measurement 
 
 
Outcome measures 
 
Neurological deficit and motor function 
 
The aim of this chapter is to explain the different methods to measure the 
functional impairment after stroke and discuss the classic way to approach 
them. Regarding to the hypothesis it is necessary to choose the best way to 
measure after stroke impairment and its impact. 
 
In 2001, the World Health Organization (WHO) [47] ratified and published the  
International Classification of Functioning, Disability and Health (ICF) [48, 49]. 
ICF explained the measurement and assessment of health and disability 
concepts [48]. 
 
This is an approach to health condition which focuses on disability and 
impairment  and  includes different  levels, to provide a scientific framework for 
classification of health conditions [48] [50]. The different levels measured in 
ICF refer to impairment, individual level activities being related to achieving a 
task or activity and social level participation in an individual’s involvement in 
life. Furthermore personal and environmental factors influence all these levels 
[48, 50-52]. 
  
Four main measurements are examined in this study, which are related to 
body function and arm activities, the Fugl-Meyer assessment, arm motor 
ability test, box and block test and grip strength test. No participation 
measures were taken in this exploratory experimental study.  
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The following diagram is a representation of the model of disability on the 
basis of ICF [47, 48](Figure1). 
 
Figure 3:  The international classification of the functioning (ICF) mode l[48, 49] . 
 
Apart from the ICF framework to classify levels of outcomes measures, having 
a set of criteria to guide the selection of outcome measures is necessary [53]. 
413 articles have been examined by the Health Technology Assessment [54] 
on methodological aspects of the use and development of patient based 
outcome measures. From their report it is recommended to use eight 
evaluation criteria, which are listed with definitions in Appendix 1. 
       Health condition 
    (disorder or disease)  
 
   Activity 
Body 
Functions 
& Structure 
 
Participation 
Environmental 
   Factors 
Personal 
   Factors 
Contextual Factors 
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Response to treatment after stroke needs to be measured and it is an 
important part of clinical assessment after stroke. It can be measured in many 
ways and the method chosen will depend on the information needed [55]. 
“Quantification of an observation against a standard” is explained as an 
outcome measure [56]. 
Several outcome measures have been involved in this study, such as stroke 
scales, psychological and cognitive measurements and also quality of life 
measurements, explained further in the Methods chapter. However regarding 
the aim of the current study some of the relevant measurements chosen as 
those measurements have been mentioned in previous articles [57-59] that 
they are the main and reliable measurements to assess stroke patient 
impairments.  
The main outcome measures for this study were measures of neurological 
deficit and motor function, the Fugl-Meyer, arm motor ability test, box and 
block test and grip strength test. Their reliability and validity have been 
established in many studies [57, 60] [58], [59], [61] and also studies focusing 
on the Grip strength test as a prognostic indicator [61]. These are explained 
below.  
 
Arm motor Fugl-Meyer assessment 
 
The Fugl-Meyer (FM) assessment is a quantitative measure for motor 
impairment after stroke which has been considered by many in the field of 
stroke rehabilitation and recommended for clinical trials of stroke rehabilitation 
and also it is the first evaluative tool to measure sensorimotor stroke recovery 
[62]. This scale is designed to assess hemiplegic patients in the post stroke 
phase of recovery and the measurement scale is divided into 5 different parts: 
1. motor function, 2.sensory function, 3.balance, 4.joint range of motion, and 
5.joint pain, and the motor part which includes measuring movement, 
coordination, and reflex action about the shoulder, elbow, forearm, wrist, hand 
19 
 
 
 
 
and the motor score from 0 (hemiplegic) to a maximum of 100 points (normal 
motor performance), which is divided into 66 points for the upper extremity 
and 34 points for lower extremity [62]. Each function scores from 0 to 2 the 
level of performance ability (0 = cannot perform, 1 = performs partially,           
2 = performs fully) and It takes around 30 minutes to complete a test [62]. 
Appendix 2 shows all the details of the Fugl-Meyer test [62]. 
 
 
Arm Motor Ability Test [25]  
 
Arm Motor Ability [25] is an instrument for assessing deficits in activities of 
daily living (ADL) [61]. ADL is an assessment used to assess the deficits in 
activities of daily living after central nervous system injuries, in addition it is 
related to several movement parameters, including strength, coordination 
between muscles and body parts, speed, active and passive range of motion, 
pain, and spasticity [61]. Its importance is to determine the patient’s condition 
severity and so make it easier to plan a treatment and assess its effectiveness 
of that [58]. 
 
The Arm Motor Ability Test [25] is a functional assessment to measure both 
quantitative and qualitative aspects of a range of ADL; it is able to assess both 
quality of movement and time of performance of upper limb movement in 
chronic stroke patients [58, 63].  
 
The AMAT assesses the effect of intervention in improving ADL function, 
originally including 16 compound ADL tasks. Each task involves one to three 
component tasks or movement segments; all components for distal and 
proximal musculature and each limb are evaluated separately. Each task’s 
compound performed continuously and the examiner can rate each 
component task according to two scales relevant to recovery of motor 
function: Functional Ability (i.e., capacity to accomplish the specified motor or 
behavioural goal) and Quality of Movement (i.e., how well the task movements 
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are executed) [58, 63]. All scales were timed separately [58]. Appendix 3 
shows the AMAT components. 
 
The AMAT scale provides information about aspects of movement that is 
difficult to assess quantitatively, especially when studying a broad range of 
tasks. It has 44 task components according to shoulder/elbow (S/E) or 
wrist/hand (W/H) movements (Appendix 3) [58] . 
 
Unilateral activities were carried out by the affected arm and bilateral activities 
were performed using dominant and non-dominant extremities in the roles in 
which they had usually been employed before the onset of hemiparesis. 
  
Box and Block Test (BBT) 
 
The Box and Block Test measures gross manual dexterity and has been used 
by occupational therapists and others to evaluate physically handicapped 
individuals [59, 64]. It is a box with a partition in the centre of the box that 
divides it into two equal sides. A number of small wooden cubes (blocks) are 
already in one side of the box and the subjects are asked to use the dominant 
hand to grasp one block at the same time and transport it to the other side of 
the partition and release it there [64]. The subject is given one minute to 
complete the test and the number of cubes transferred to the other side is 
counted [57]. The test is then repeated with the non-dominant hand [64]. 
 
 
Grip strength test 
 
The strength of voluntary grip is an indicator of arm function recovery after 
stroke and it can be measured by using a sensitive electronic dynamometer 
[61]. Normally it is reported by calculating the mean of three maximum grip 
strength tests. 
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In summary in order to explore the impact of stroke on body function Arm 
motor ability test, Arm motor Fugl-Meyer test, box and block test and grip 
strength measurements were selected. In this provision study exploring 
mechanism; participation and activity measures were not explored. 
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Chapter 3 – Imaging 
 
 
Magnetic Resonance Imaging (MRI) 
 
This chapter is a general introduction about the concept of physics in MRI and 
different type of image acquisition such as T1 and T2. In addition, the different 
methods of analysis which have been used for this study will be discussed.  
 
Since the early 1980s, MRI has been shown to be a sensitive technique to 
monitor and measure intracranial disease. Structural MRI provides extensive 
details about the anatomical structure of the brain [65]. It is becoming 
increasingly important to explore cortical changes associated with the normal 
aging process or further changes regarding different diseases such as 
dementia illnesses (Alzheimer’s disease (AD)), and it is also very sensitive to 
cerebral white matter diseases and is the only sensible imaging test for 
Multiple Sclerosis (MS) . As long as contrast is used it is sensitive to diseases 
that involve the pial meninges, which could otherwise be easily missed [66].  
 
Furthermore structural MRI is an essential tool for clinical care for patients 
with brain diseases and it is used for clinical trials to identify response to 
treatment [66]. Since MRI’s introduction into clinical practice in the early 
1980s, it is estimated that over 20 million scans are carried out worldwide 
each year without any problem with safety, so safety is a big  advantage for 
MRI scanning [65]. 
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Although MRI is an extremely safe form of medical imaging there are specific 
interactions between the scanner and the patient that need to be mentioned 
as potential safety hazards, which correspond to the static magnetic field 
produced by scanner, radio-transmitting  and receiving coils, which excite and 
detect the MR signal, and magnetic field gradients, which localize the MRI 
signals [65, 67]. 
    
Physical basics of magnetic resonance 
 
Magnetic resonance imaging relies on spinning motion of the nuclei present in 
human tissues [68]. Atoms contain three types of particles: protons (positively 
charged), neutrons (no net charge) together within an atom and electrons 
(negatively charged) [69].  
 
Different atoms have different nuclear contents and atoms with an odd 
number of protons and/or neutrons have non-zero ‘spin’ and are therefore 
detectable using MRI. For instance hydrogen nuclei have a single proton. 
Hydrogen is the most abundant atom in the human body, so hydrogen is the 
most commonly imaged nucleus in MRI [68-70]. 
 
As hydrogen has a spin so it can possess electrical charge and spinning of a 
charged particle like hydrogen nucleus creates a magnetic field around it and 
it works as a magnet (Figure 2), it has a north and south pole with equal 
strength. It has a magnetic moment shown by a vector. The direction of that 
vector shows the direction of magnetic moment and the length of the vector 
shows the size of the magnetic moment (Figure 4) [68].  
 
In the absence of an external magnetic field the magnetic moments of the 
hydrogen atoms are oriented randomly but when a magnetic field exists the 
majority of the magnetic moments of hydrogen nuclei align with the magnetic 
field (Figure 3) [68, 70].  In the magnetic field the majority of hydrogen proton 
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spins align parallel to the magnetic field and create a net magnetization in the 
direction of the applied field [70]. 
 
So in MRI when a radiofrequency [71] pulse is transmitted to the subject, the 
signal is received from the magnetized spin of proton in the body [71] [70]. In 
magnetic resonance imaging, the main magnetic field of scanner is often 
indicated with the symbol B0 [68].   
 
 
                                         
    
Figure 4: Left: without an external magnetic field a proton rotating around its own axis 
and generate a magnetic field. Right: The magnetic moment of a hydrogen nucleus, it 
shows the magnetic vector with the direction and size [70] [68]. 
 
 
                       
 
Figure 5: Left: random alignment in the absence of an external magnetic field. Right: 
alignment with the magnetic field that is shown by the large white vector [68]. 
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T1 and T2 contrast  
 
Different contrast can be generated in the MRI scan which is related to 
exchanging the energy of hydrogen nuclei [68]. The process by which 
hydrogen loses energy is called relaxation. In this process individual spins go 
back to their energy state which is in the direction of the magnetic field. This 
causes the recovery of magnetic moments of nuclei and causes them to give 
up energy to the surrounding environment. This process is termed T1 
recovery which is the recovery of longitudinal (z) magnetization [68, 70]. 
 
There are two important factors that govern the time at which MR images are 
collected. The first factor is the time interval from the application of one radio 
frequency (RF) pulse to the application of next RF pulse, which is known as 
repetition time (TR) and is measured in milliseconds (ms) and the second 
factor is the time interval from application of one RF and data acquisition, 
which is known as echo time, or TE and is also measured in ms [68, 69]. 
 
TR determines the amount of relaxation that is allowed to be between the end 
of one RF pulse and the application of the next one [68]. TE determines the 
amount of decay of transverse magnetization is allowed to occur [68, 70]. 
 
By changing the scan TR and TE, the contrast between different tissues types 
is changed T1-weighted and T2-weighted images are two types of different 
contrast that are possible to have from MRI. To generate images sensitive to 
T1 contrast, a pulse sequence with intermediate TR and short TE must be 
collected and T2 is the “transverse” relaxation time and to generate images 
sensitive to T2 contrast, a pulse sequence with long TR and intermediate TE 
must be collected [69].  
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In the other words TR determines the amount of T1 relaxation that has 
occurred when the signal is read and TE controls the amount of T2 relaxation 
that has occurred when signal is read [68]. Figure 6 shows samples of T1- and 
T2-weighted images. 
 
The most commonly used structural contrast for anatomical images of the 
brain is T1-weighted images and T2-weighted images are used to detect 
characteristic  pathological changes, for example in Multiple Sclerosis [67].  
 
               
     
Figure 6: T1-(left) and T2-weighted (right) axial cross-sections for tissue 
segmentation. 
 
 
FMRIB’s Software Library (FSL) 
 
FSL is a comprehensive library of analysis tools for MRI, functional MRI, and 
DTI brain imaging data. FSL is written mainly by members of the Analysis 
Group, FMRIB, and Oxford, UK. FSL runs on Apple, PCs (Linux and 
Windows) and is very easy to install. Here are the definitions of different FSL 
tools which have been used for this analysis.  
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FIRST (FMRIB's Integrated Registration and Segmentation 
Tool)  
 
FIRST is a model-based segmentation/registration tool. The shape/ 
appearance models used in FIRST are constructed from manually segmented 
images provided by the Centre for Morphometric Analysis (CMA), MGH, 
Boston [74]. 
 
FIRST program consists of a series of steps. Initially, the skull is removed 
from the brain image and affine registration is carried out to standard space 
(which is MNI152 space at 1mm resolution) [75].  
 
In the next step segmentation is used to segment a single structure then 
segmentation of all modelled brain structures is carried out based on that first 
segmentation in the model. FIRST provides model files for the Caudate, 
Hippocampus, Lateral Ventricules and Amygdala, and it uses Thalamus as a 
reference [75, 76]. In addition, there is way and easy command to use FIRST 
which does all of the above, including registration and segmentation of 
subcortical structure in the models, and producing a summary segmentation 
image for all structures [75-77].  
 
In addition there is an option in FIRST that helps boundary correction on all 
the models (structures). It will automatically parallelise the fitting of each 
structure [75-77]. 
 
After these processes it is possible to estimate the volume of each of the 
segmented areas with FIRST program. 
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FREESURFER  
 
The cortex is a highly folded area of brain that is outside of the white matter 
and it is between 1 to 4.5 mm with an average of 2.5 mm. Therefore cortical 
thickness measurement carried out in 3-D is important [78, 79].  
Traditional measurement of cortical thickness was based on folded 2-D 
surfaces which was measured by drawing contours from each part on to thin 
wax sheets and then arrange the sheets in order for viewing [80], 
 
 De Yoe et al 1996 used a computerised version of this method for some 
human neuroimaging data [81] but it is time consuming. The other method is 
to estimate the thickness of cortical areas manually but it is also time 
consuming and needs a trained anatomist, and it can still has some errors as 
the folded cortex in some areas can not  be perpendicular to any of the 
original axes [79]. Therefore an automated and accurate method should be 
used for cortical thickness measurement. 
FreeSurfer is a set of software tools for the study of cortical and subcortical 
anatomy and also cortical reconstruction and volumetric segmentation [82]. 
The technique is explained in prior publications [79, 80, and 83] [84, 85]. 
 
This surface based analysis includes several stages. First, the volume is 
registered with the Talairach atlas using an affine registration [86, 87] and the 
B1 bias field is estimated regarding the variation of white matter intensity 
measurement and based on the location of white matter in Talairach space 
and also the intensity of the local neighbourhood areas [82]. Then the skull is 
stripped and as well as cerebellum and brain stem and the point of cutting is 
based on the Talairach location of corpus callosum and pons [66, 82, and 83]. 
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In the cortical surface, this software is able to define a boundary between 
white matter and cortical gray matter and also a boundary between gray 
matter and CSF at the pial surface [80] (Figure 5). The cortical thickness that it 
measures is the distance between the gray/white boundary and the pial 
surface [88]. Cortical and subcortical areas are segmented and both 
segmentation and labelling use the same basic algorithm [86, 87]. The result 
of freesurfer software is shown in Figure 6, which shows the volumetric 
labelling of white matter including several subcortical structures [82].   
 
After this process anatomical measures become possible, including: cortical 
thickness, surface area, curvature, and surface normal at each point on the 
cortex. The distance between the white and the pial gives us the thickness at 
each location of cortex [79]. 
 This software is able to make the surfaces inflated and/or flattened for 
improved visualization. In addition, a cortical surface-based atlas has been 
defined based on average folding patterns mapped to a sphere [84].  
 
 
Figure 7:  Three stages from the Freesurfer cortical analysis pipeline. Left: skull 
stripped image. Middle: white matter segmentation. Right: surface between white and 
gray (yellow line) and between gray and pia (red line) overlaid on the original T1-
weighed. 
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Figure 8: Left: Volume-based labelling. Cortical gray matter and white mater are 
represented by single classes. There are separate labels for the structures in each 
hemisphere. Right:  Surface-based labelling. 
 
A 3D view of the pial surface is shown in Figure 7, Left. This surface can be 
inflated to show the areas in the sulci as shown in Figure 7, Right. This 
surface can then be registered to the spherical atlas based on the folding 
patterns [89]. 
 
 
 
Figure 9: Left: Showing the pial surface, Right: showing Sulci in Red colour and Gyri 
in green colour.  
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Chapter 4 – Method 
 
 
Introduction 
 
This chapter is to determine the data (patients and normal subjects) 
recruitment method such as the necessary different assessments before 
recruiting and also inclusion and exclusion criteria. 
The research was performed on pre-existing data. The Local Institutional 
Review Boards granted ethical approval for Northwestern University in 
Chicago (Northstar Neuroscience Protocol V0267: Safety and Effectiveness of 
Cortical Stimulation in the Treatment of Upper Extremity Hemiparesis). 
 
Protocol  
 
Patients were recruited from a pool of patients known to study personnel 
(therapists, physiatrists), through direct mailing, radio advertisement with call-
in centres, at stroke support groups (study personnel went and gave talks 
discussing the study), via advertisements on hospital websites, and via flyers 
posted in hospitals [90]. 
 
All participants reviewed and signed an informed consent form before 
enrolment for inclusion. Each patient was individually screened regarding the 
inclusion and exclusion criteria, as described later. 
All subjects were tested with the Edinburgh handedness test [91] to confirm 
their handedness and all subjects were right handed except three.  
 
Eligible participants attended for structural brain imaging in three centres by  
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3-T scanners. Following brain imaging all participants underwent basic 
medical evaluation including complete medical history, blood tests, 
electrocardiogram and chest x-ray. Then the following outcome measures 
were assessed: 
 
Measures of Neurological Deficit and Motor Function 
Arm Motor Fugl-Meyer (AMFM)[62] 
Box and Block Test [64] 
Grip strength [61] 
 
 
Measures of Activities of Daily Living (ADL) [61] 
Arm Motor Ability Test [25] 
Canadian Occupational Performance Measure (COPM) [92] 
 
Stroke Scales 
National Institutes of Health Stroke Scale (NIHSS) [93] 
Stroke Impact Scale (SIS) [94] 
 
Psychological and Cognitive Measures 
Mini-Mental Status Examination [95] 
Beck Depression Inventory [96] 
 
Measures of Quality of Life 
Stroke-Specific Quality of Life scale(SIS-QOL)[97] 
Short Form-36-Item (SF-36) Health Survey [98] 
 
 
Thus the patients who were recruited had ischemic stroke which occurred at 
least 4 months previously, arm motor Fugl-Meyer score between 20-50 points, 
active wrist extension of at least 5°, age ≥ 21 years, no history of seizure, no 
substantial neglect, depression, or sensory deficit. Patients who took 
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amphetamine, antiepileptic, anxiolytics, or antidepressants, which could 
confound the study, had been excluded. Complete inclusion and exclusion 
criteria are listed below. 
 
 
Inclusion criteria 
 
1. Subjects must have an ischemic vascular lesion that is: 
 
Cranial computed Tomography or MRI confirmed ischemic stroke above level 
of brainstem resulting in neurological deficit  
Ability to comply with rehabilitation protocol 
Stroke lesion Is at least 4 months old, has been documented by computerized 
tomography (CT) or magnetic resonance imaging (MRI).  
This lesion results in the neurologic deficit defined in the study inclusion and 
exclusion criteria and is considered the “index stroke”. 
 
2. The index stroke must be the most recent stroke. 
 
3. Subjects are medically and neurologically stable, as determined by medical 
history and documented neurological examination. 
 
4. Moderate to moderately severe upper-extremity hemiparesis, defined as an 
arm motor Fugl-Meyer score between 28 and 50 (inclusive), and either active 
Wrist extension of at least 5 degrees or ability to perform a repetitive grasping 
task. 
 
5. Age 21 years or older. 
 
6. For women of childbearing potential, a negative serum BhCG pregnancy 
test within 2 weeks prior to study entry, and willingness to practice adequate 
Contraception during the study. 
34 
 
 
 
 
 
7. Ability to comply with the study rehabilitation protocol. 
 
 
Exclusion criteria 
 
Study subjects must not meet any of the following exclusion criteria: 
 
1. Primary hemorrhagic stroke. It is recognized that some ischemic strokes 
may have a minor amount of hemosiderin in the parenchyma.  If this occurs, 
this is not considered a “hemorrhagic stroke” referred to in this exclusion 
criterion. 
 
2. Any additional stroke (other than the index stroke) associated with 
incomplete motor recovery. 
 
3. Any neurologic or physical condition that impairs function of the target 
extremity. 
 
4. History of seizure disorder or a spontaneous seizure that has occurred one 
month or longer from index stroke or patients who have had a documented 
bout of status epilepticus. 
 
5. Neurological condition that would likely reduce the safety of study 
participation, including central nervous system (CNS) vasculitis, intracranial 
tumour, intracranial aneurysm, multiple sclerosis [99] or arteriovenous 
malformations (AVM). 
 
6. Moderate to severe hemispatial neglect and/or anosognosia involving the 
affected limb. 
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7. Severe sensory deficit, defined as a score of 2 on part 8 of the NIH Stroke 
Scale. 
 
8. Inability to understand, cooperates, or complies with the study procedures. 
 
9. Severe spasticity, defined as an Ashworth score of 4 on any upper 
extremity region. 
 
10. Any medications 6 weeks prior to enrolment or Botox injections in the 
affected arm 4 months prior to enrolment which cause changes in spasticity. 
 
11. Major active psychiatric illness that may interfere with required study 
procedures or treatments as determined by the enrolling physician. 
 
12. Untreated or inadequately treated depression defined by a score of 19 or 
greater (out of 63) on the 21-question version of the Beck Depression 
Inventory. 
 
13. Modified Rankin Score of 4 or more. 
 
14. A substantial cardiopulmonary or metabolic disorder. This includes a 
current serum creatinine >3.0 mg/dL, a total serum bilirubin >2.0 mg/dL, or 
advanced chronic obstructive pulmonary disease. 
 
15. Increased risk for myocardial infarction or other major medical 
complications of general anaesthesia or surgery. Exclusions include, but are 
not limited to, subjects with unstable angina, decompensated congestive heart 
failure, severe cardiac valvular disease, a high-grade atrio-ventricular (AV) 
block on EKG, or a symptomatic ventricular arrhythmia or a myocardial 
infarction within 6 months prior to enrolment. 
 
16. Terminal illness associated with survival <12 months. 
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17. Inability to discontinue antithrombotic therapy (e.g. antiplatelet agents or 
anticoagulants) preoperatively for device implantation and removal. 
 
18. Introduction in the 2 months prior to enrolment of a potentially confounding 
central nervous system (CNS) drug (e.g., amphetamines, antiepileptics, 
anxiolytics, and antidepressants). 
 
19. History of spinal cord injury, traumatic brain injury, or spontaneous 
subdural or epidural hematoma that has resulted in a neurologic deficit. 
 
20. Current abuse of alcohol or drugs, prescription or otherwise. 
 
21. Contraindication to stimulation system placement surgery. 
 
22. Contraindication to magnetic resonance (MR) imaging. This may include 
weight incompatible with scanner, metallic devices such as some aneurysm 
clips or shrapnel, certain eyeliner tattoos, or implanted electrical devices (e.g., 
cardiac pacemaker, implantable cardioverter defibrillator (ICD), or a spinal 
cord Stimulator). 
 
23. Nursing a child, pregnancy, or intent to become pregnant during the study. 
 
24. Participation in another drug, device, or biological trial within the 30 days 
prior to enrolment. 
 
25. Patient has a condition that, in the opinion of the investigators, would 
interfere with study compliance or safety. 
 
26. Patients who would require diathermy during the study period where an 
investigational device may be implanted (i.e., through follow-up week 8). 
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27. Patients who would require an MRI during the study period where an 
investigational device may be implanted (i.e., through follow-up week 8). 
Data selection was performed under the supervision of an experienced 
neurologist (Dr Mojtaba Zarei). Cases were excluded who had massive 
damage or had global brain atrophy which was not the current study interest 
or had a different type of stroke from Striato-capsular stroke. Only patients 
with stroke affecting the posterior limb of the internal capsule stroke and/or 
striatum were selected.  
 
 
Normal subject data 
 
Normal subjects were selected from 416 subjects from Open Access Series of 
Imaging Studies (OASIS) which will be explained in the next paragraph.  
 
Different information from normal subjects was downloaded such as 
descriptive data, cortical thickness, and cortical volume. Because the normal 
subjects were not from the same centres as patients, in some ages it was 
impossible to get an exact age match. To reduce this bias, for each patient 3 
normal subjects that were sex matched and with a similar age were chosen. 
Thus 63 normal subjects were selected versus 21 patients. 
All the normal subjects were right handed but in the patient group there were 3 
left handed subjects which were all in the left hemispheric stroke group. The 
age of both groups is between 30 to 78 years.  
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OASIS data 
 
Data from Open Access Series of imaging Studies (OASIS) were used to form 
the healthy control group. 
 
OASIS is a series of magnetic resonance imaging (MRI) data sets that is 
publicly available for study and analysis [100]. The initial data set consists of a 
cross-sectional collection of 416 subjects aged 18 to 96 years with and without 
dementia which have been selected from a larger database of individuals who 
had participated in MRI studies at Washington University based on the 
availability of at least three acquired T1-weighted images, right-hand 
dominance and a recent clinical evaluation for older adults [100]. 
 
One hundred of the included subjects older than 60 years have been clinically 
diagnosed with very mild to moderate Alzheimer's disease. We have excluded 
these subjects from the control group. The OASIS database  has provided 
data that would be difficult for individual laboratories to acquire [100]. So 
providing a normal group in comparison with patients, 63 normal age and sex 
matched subjects have been selected among the normal subjects from the 
OASIS data.  
For each subject, three or four individual T1-weighted magnetization images 
were acquired on a 1.5T Vision scanner (Siemens, Erlangen, Germany) in a 
singe imaging session [100] and for this study just one session scan has been 
used. The effect of  cross-scanner is negligible as it has shown at Xiao Han 
study [101].  
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Chapter 5 – MRI analysis 
 
 
MRI data 
This chapter discusses step by step image analysis to define the cortical and 
subcortical areas. Furthermore calculating the cortical thickness and stroke 
lesion volume will be explained with the related soft wares. 
 Each image was analysed by using the FSL program [73, 102]. FSL included 
different Tools for different aims of analysis are as follows: 
Stage 1: The brain extraction tool [103] [104] was used to delete non-brain 
tissue from the image of the whole head (Figure 10,11), this process was 
done for each case. Some images included neck as well; therefore before 
processing them in Brain extraction tool (BET), neck and extra artefacts had to 
be removed by hand to have a perfect brain image. 
Stage 2: In the next step the stroke lesion of each case was masked manually 
in FSLVIEW (an interactive display tool for 3D and 4D data) using 3D mode 
[105], under the supervision of an experienced neurologist.  
Stage 3: After masking the lesions, all lesions were overlapped on each other 
by FSL program to create a population map of all cases, which shows the 
region of stroke in striatum and posterior limb of internal capsule. Figure 12 
shows the population map of the region of interest. In addition the volume of 
lesion areas have been calculated by FIRST (FMRIB integrated and 
Registration and Segmentation Tool) [75-77]. 
At the first attempt for analysing MRI data, FMRIB’s Integrated Registration 
and Segmentation Tool (FIRST) [106, 107] were used to register the T1-
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weighted structural image. This carried out the affine transformation to 
standard space to MNI152 space at 1mm resolution and then the subcortical 
structures were segmented with applying boundaries for each region (Figure 
13). 
 
 
 
 
 
 
 
 
 
Figure 10: T1 weighted structural MRI: image shows stage 1 before removing the 
skull. 
 
 
 
 
 
 
 
 
Figure 11:T1 weighted structural MRI: image shows stage 1 after removing the skull. 
Elham Zareh                                11
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Figures 12: Population map of subcortical stroke lesion sites (in 2D); red colour 
shows the majority of stroke lesions were located in the striatum and posterior limb of 
internal capsule, n= 21.  
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Figure 13: Registered and segmented brain image opened in FSLVIEW. Different 
areas in left side of brain separated by colour; Light blue: Putamen. Pink: Caudate. 
Blue: Thalamous. Yellow: Globus Pallidus. Green: Hippocampus. The right side of 
the brain shows exactly the same areas but has not been coloured. 
 
 
Constructing contrast matrices to test the hypotheses  
 
Statical analysis of cortical thickness data  
 
Freesurfer was used to define surfaces for all subjects; after all surface 
reconstruction was completed for all subjects in the study. FreeSurfer's 
mri_glmfit command was used to perform inter-subject/group averaging and 
inference on the cortical surface. Mri_glmfit models the data as a linear 
combination of effects related to variables of interest, confounds and errors, 
and permits statistical inferences to be made about effects of interest in 
relation to error variance. It also allows for certain permutation testing and 
Elham Zareh                                14
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other means for correcting for multiple comparisons. For group analysis, this 
technique fits a general linear model (GLM) at each surface vertex to explain 
the data from all subjects in the study.  
 
 
Functional assessment  
 
Four behavioural measurements were utilised in this study, which focused on 
upper limb function, which have been explained with details in the Introduction 
and in the early section of the Methods chapter. They are AMAT and FMAT, 
which are based on some criteria such as activity of daily living and 
sensorimotor stroke recovery, respectively. BBT was done as a manual 
dexterity test and Grip strength test measured grip power directly. All the 
functional assessment was done in the standard protocol order with the SPSS 
version 16. 
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Chapter 6 – Results 
 
 
Introduction 
 
 
The hypothesis of this study is that striato-capsular stroke has an effect on 
cortical thickness, and affects the functional measurement scores after stroke.  
Also, the thickness of cortex could be related to the size of stroke. 
 
As shown in Table 1 age and sex in patient groups is similar to the control 
group. The patients are in two groups of left-hemisphere stroke and right-
hemisphere stroke. The time after stroke is varies with the minimum of 4 
months and the maximum of 419 months after stroke and the mean and 
standard deviation are calculated that is (53.89 ±93.60). The information about 
the number of months after stroke was available for 19 out of 21 patients. 
 
The regions of interest of this study are the areas related to motor function 
(motor cortex, premotor cortex, supplementary motor area and somatosensory 
cortex cortex). These areas were chosen because they are involved in 
planning and initiation of movement, regulating posture and voluntary 
movement. Results were considered with a significant level of p‹0.05. 
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Hand Dominancy  
Female
 
Male
 
Age ( mean ± SD)Right Left 
Left-Sided Stroke 11 3 6 8 32-68 (50±9) 
Right-Sided Stroke 7 0 3 4 51-78 (60±8) 
Control 63 0 33 30 33-78 (54±10) 
 
Table 1:  Demographic data 
 
 
Freesurfer was used  to measure cortical thickness in the primary motor 
cortex (M1) .We used the SIENA tool, which is a package to estimate atrophy 
(volumetric loss of brain tissue) to quantify stroke volume[102, 108]. The 
descriptive analysis of the M1 thickness and stroke volume in the left-
hemisphere and right-hemisphere stroke groups is shown in Table 2. 
 
Cortical thickness of all cortical areas has been calculated and also the 
volume of all subcortical and cortical areas, which is addressed respectively in 
Appendices 4, 5 and 6.  
 
 
Table 2: Descriptive values of stroke volume and cortical thickness at the affected 
and unaffected side of brain. Left: left hemispheric stroke group, Right: right 
hemispheric stroke group. 
Stroke_side N Mean SD 
Left 
Stroke Volume 14 1902.7  ml 1557.9   ml 
Contralesional M1 Thickness 14 2.50      mm 0.135     mm
Ipsilesional M1 Thickness 14 2.44      mm 0.148     mm
Right 
Stroke Volume 7 4161.6  ml 3841.2   ml 
Contralesional M1 Thickness 7 2.42      mm 0.163     mm
Ipsilesional M1 Thickness 7 2.32      mm 0.169     mm
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1. Difference in cortical thickness in the affected hemisphere 
in both left and right hemispheric stroke groups versus the 
control group.  
 
Vertex-wise group comparisons with Freesurfer software were carried out 
between left-hemisphere and right-hemisphere stroke patients and the control 
group. The left-hemisphere stroke group showed significant reduction 
compared to controls in the dorsal and medial prefrontal cortex, premotor, 
posterior parietal, precuneus, and temporal cortex which survived after 
correction for multiple comparisons using false discovery rate (FDR), Similar 
comparisons for the right-hemisphere stroke group showed a similar pattern of 
cortical thinning, however on visual inspection the extent of cortical thinning 
was much less than that of the left-hemisphere stroke patients (Figures 15 
and 16). Primary motor cortex was notably spared in both stroke groups.  
 
To directly compare left and right hemisphere stroke subjects, we performed a 
ROI analysis on cortical thickness. 
 
 
  
Within-subject effects  
 
The main effect of hemisphere (ipsilesional and contralesional) was significant 
((f (1, 19) = 5.146), p= 0.035). This shows cortical thickness reduction was 
greater in the ipsilesional hemisphere. 
 
The main effect of area (cortical ROI) was significant (f (9,171) =37.051,  
p= 0.0001) with thickness varying between cortical regions. Cortical ROI were: 
caudal anterior cingulate, caudal middle frontal, inferior parietal, paracentral, 
parsopercularis, posterior cingulate, precentral, superior parietal, superior 
temporal and postcentral. 
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Between-subject effects  
 
The main effect of stroke side was significant (f (1, 19) =6.909, p=0.017), 
therefore there was a significant difference in cortical thickness between left 
hemisphere stroke and right hemisphere stroke patients.  
 
Calculating the mean cortical thickness across ROIs revealed that the left 
hemisphere stroke side group had a thicker cortex on average (mean=2.463, 
sd= 0.020) compare to the right hemisphere stroke side group (mean=2.372, 
sd= 0.028).  
 
The small colour bar at the right side of images shows that the higher difference is 
seen in yellow colour which is considered as a significant difference. The gray colour 
shows definitely no significant changes.  
 
 
 
 
Figure 14: Left-hemisphere stroke results versus control group.  
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Figure 15:  Right-hemisphere stroke results versus control group. 
 
 
 
2. Difference in M1 thickness between the right hemispheric 
stroke and control group and between the left hemispheric 
stroke group and controls.  
 
An independent sample t_test found that no significant difference in M1 
thickness between left hemispheric stroke and control groups (t=1.24, n=14, 
p>0.05). Similarly, there was no significant difference in M1 thickness between 
the right hemispheric stroke and controls (t=-0.511, n=7, p>0.05). These 
results showed that, although the stroke has widespread effects on cortical 
thickness relative to controls (Figure 10 and 11) thinning was not significant in 
M1. To test whether variation in M1 thickness correlates with variation of 
stroke volume, variation of stroke volume in patients was calculated. 
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There was a significant negative correlation between M1 thickness on the side 
of stroke (ipsilisional precenteral cortex) and stroke volume (r = -0.439, n = 21, 
P=0.023 one-tailed, P< 0.05) Table 3 and Figure 17. 
 
 
 
Table 3: Correlation Test, correlation between affected M1 thickness and stroke  
volume. 
 
 
As it shown in Figure 17 there are some data that seems to be far from the 
other values, which are called statistical outliers [109] therefore Grubbs’ test 
[110] was performed as a method to determine whether any of the values of 
data was a significant outlier from the rest or not.  
 
The Grubbs’ test calculation for the number of 21 subjects with the 
significance level of 0.05 (two-sided) clarified that there is no significant outlier 
data in the list of data entry (M1 thickness and stroke volume).  
 
 
 
 
 
 
 
Ipsilesional M1 Thickness 
 
Stroke Volume 
Pearson correlation -0.439 
Sig.(1-tailed) 0.023 
N 21 
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Figure 16: Correlation between ipsilesional M1 thickness (mm) and stroke volume 
(ml), the red line shows the average of the M1 thickness in control group. 
 
 
 
In addition the correlation between the ‘’ time since lesion’’ and different functional 
test were not significant (p>0.05) (Table 4).Also the correlation between the size of 
lesions (stroke volume) and functional tests were not significant (p>0.05). See 
Table5. 
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Table 4: Correlation between the different functional tests and “time since 
lesion”. GSTEST: Grip strength test, AMFT: Arm motor fugl-meyer, AMAT: 
Arm Motor Ability Test, BBT: Box and Block Test. 
 
 
 
Table 5: there is Correlation between different functional tests and stroke 
volume. GSTEST: Grip strength test, AMFT: Arm motor fugl-meyer, AMAT: 
Arm Motor Ability Test, BBT: Box and Block Test. 
 
 
 
  GSTEST AMFM AMAT BBT 
Time since 
Lesion 
Pearson 
Correlation 
 
-0.0504 
 
 
-0.125 
 
-0.265 
 
-0.262 
 
Sig.(1-tailed) 0.438 0.316 0.144 0.147 
N 12 17 18 18 
  GSTEST AMFM AMAT BBT 
Stroke 
Volume 
Pearson Correlation 0.258 0.070 -0.169 -0.077 
Sig.(1-tailed) 0.187 0.388 0.239 0.373 
N 14 19 20 20 
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3. Cortical thickness in controls: hemispheric asymmetries 
and effects of age and sex. 
 
Repeated measures ANOVA, comparing left and right hemispheres in 66 
areas in control subjects (63 subjects) showed no significant effect of side (F 
(1, 62) =0.578, P>0.05). 
 
Bivariate correlation with Pearson’s Correlation Coefficient between age and 
cortical thickness of cortical areas in normal subjects showed negative 
significant correlation (1-tailed, p<0.0007, manual correction for multiple 
comparisons) in M1, superior frontal, lingual cortex at both side of the brain 
and also negative significant correlation in superior temporal cortex and 
isthmus cingulated cortex on the left side of brain and supramarginal cortex on 
the right side of brain. Table 4 shows the significant areas with details. 
 
 
 
Repeated measurement ANOVA for sex and cortical thickness of brain areas 
(66 areas) demonstrated no significant differences (f=0.393, sig=0.533) in 
cortical thickness between female and male, (Male: n=30, Female: n=33, 
p>0.0007 corrected for multiple comparison). 
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List of areas 
Correlation between  cortex 
Area and Age 
Left precentral (M1) 
Pearson correlation 
Sig (1-tailed) 
-0.452 
0.00009 
Right precentral (M1) 
Pearson correlation 
Sig (1-tailed) 
-0.437 
0.0001 
Left superior frontal 
Pearson correlation 
Sig (1-tailed) 
-0.537 
0.000002 
Right superior frontal 
Pearson correlation 
Sig (1-tailed) 
-0.410 
0.0004 
Left  Lingual 
Pearson correlation 
Sig (1-tailed) 
-0.456 
0.00008 
Right Lingual 
Pearson correlation 
Sig (1-tailed) 
-0.412 
0.0003 
Left superior temporal 
Pearson correlation 
Sig (1-tailed) 
-0.427 
0.0002 
Left  isthmus cingulate 
Pearson correlation 
Sig (1-tailed) 
-0.460 
0.00007 
Right supramarginal 
Pearson correlation 
Sig (1-tailed) 
-0.505 
0.00001 
 
Table 4: Correlation between the thickness of cortical areas (66 areas) and age, 
p<0.0007.  
 
 
4. Correlation between stroke volume and functional tests 
  
Bivariate correlation with Pearson’s Correlation Coefficient with SPSS 16, 
demonstrated no significant correlation between different functional tests (Grip 
Strength Test, Arm Motor Ability Test, Arm Motor Fugel Mayer Test and Box 
and Block Test) and stroke volume. Table 6 shows the descriptive analysis of 
different functional tests. 
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Descriptive analysis of functional test shows in Table 6. The results illustrate 
that stroke volume does not relate with the score of the functional tests (Table 
7). As it has assumed that the sample size was not enough for this correlation, 
the sample size for the power of 80% has calculated. It has been named as 
Estimated sample size described in Table 6, that calculated by sample power 
2 program (SPSS16’s product) (Table 6). 
 
 
 
 
Descriptive Analysis  
 
 N Mean STD.Deviation 
GSTEST 14 16.55 13.30 
AMFM 19 35.97 6.05 
AMAT 20 3.12 0.70 
BBT 20 19.50 13.17 
 
Table 5:  Descriptive analysis of functional test. GSTEST: Grip Strength Test, AMFM: 
Arm Motor Fugel Meyer Test, AMAT: Arm Ability Test, BBT: Box and Block test. 
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 Correlation Test 
 
Table 6: Correlation between Stroke Volume and Functional Tests, GSTEST: Grip 
Strength Test, AMFM: Arm Motor Fugel Meyer Test, AMAT: Arm Ability Test, BBT: 
Box and Block test. Estimated sample size is a sample size which is able to show the 
correlation with the power of 80% and α = 0.05. 
 
 
5. Correlation between the precentral cortex (Motor Cortex) 
and functional tests 
 
Bivariate correlation with Pearson’s Correlation Coefficient with SPSS16 was 
carried out. There was no significant correlation between the functional tests 
 Stroke Volume 
GSTEST Pearson Correlation 
Sig. (2-tailed) 
N 
Estimated sample size 
0.258 
0.373 
14 
110 
AMFM                   Pearson Correlation 
Sig. (2-tailed) 
N 
Estimated sample size 
0.070 
0.776 
19 
1600 
AMAT Pearson Correlation 
Sig. (2-tailed) 
N 
Estimated sample size 
-0.169 
0.477 
20 
266 
BBT Pearson Correlation 
Sig. (2-tailed) 
N 
Estimated sample size 
-0.077 
0.746 
20 
1221 
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and motor cortex thickness. In other words the thickness of the precentral 
cortex on the side of stroke does not have any effect on the functional score 
tests (Table 7). Sample size also has been calculated by Sample Power 2 
program for the power of 80%, to show if the current study sample size is 
enough to calculate the correlation or not. The estimated   required sample 
size is higher than the current sample size for all correlation tests (Table 7). 
 
 
Correlation Test Ipsilesional M1 Thickness 
GSTEST Pearson Correlation 
Sig. (2-tailed) 
N 
Estimated sample size 
-0.194 
0.507 
14 
214 
AMFM                    Pearson Correlation 
Sig. (2-tailed) 
N 
Estimated sample size 
0.116 
0.636 
19 
545 
AMAT Pearson Correlation 
Sig. (2-tailed) 
N 
Estimated sample size 
0.200 
0.398 
20 
190 
BBT Pearson Correlation 
Sig. (2-tailed) 
N 
Estimated sample size 
0.126 
0.597 
20 
460 
 
Table 7: GSTEST: Grip Strength Test, AMFM: Arm Motor Fugel Meyer Test, AMAT: 
Arm Ability Test, BBT: Box and Block test. Estimated sample size is a sample size 
which is able to show the correlation with the power of 80%. 
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Chapter 7 – Discussion 
 
 
 
 
Patient group 
 
The study demonstrated cortical thickness changes in striatolenticular chronic 
stroke patients which included individuals with right and left hemispheric 
stroke with moderate to moderately severe upper-extremity hemiparesis. 
 
Voxel-based comparison of cortical thickness measures observed reduced 
thickness in most areas of the cortex in left hemisphere stroke patients 
compared to a control group, similar results were observed in right 
hemisphere stroke patients although the results suggest less extensive 
reductions in cortical thickness in the right hemisphere stroke group compared 
to controls. 
 
This result could perhaps be explained by the smaller number of right 
hemisphere stroke patients (n=7) compared to left hemisphere stroke patients 
(n=14) which would result in lower power for comparisons between right 
hemisphere stroke patients and controls. These apparent differences in 
thickness reduction between the left and right hemisphere groups were not 
tested statistically in the voxel-based analysis.This is because it is not 
possible to directly compare the left and right hemisphere stroke group with a 
voxel-wise analysis (without first flipping the brains so that all stroke appear in 
the same hemisphere) and so direct comparisons between groups were 
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instead performed with a region of interest analysis. A direct comparison 
between stroke groups using a region of interest analysis showed that side of 
stroke did have a significant effect on the brain cortical thickness reduction: 
the left hemisphere stroke group had a thicker cortex than the right 
hemisphere stroke group.  
 
This finding was surprising given the results of the voxel-wise analysis 
showing particularly prominent thickness reductions in the left hemisphere 
stroke group. The thicker cortex in the left hemisphere stroke group suggested 
by the regions of interest analysis could be due to the fact that majority of 
patients were right handed; perhaps a stroke to the dominant hemisphere has 
less severe effects on cortical thickness. Another interpretation of this result is 
that it is due to the stroke volumes being larger on average for the right 
hemisphere stroke group. 
 
The current study tested the role of the side of stroke which has previously 
received limited research interest. One article, by Kwon and colleagues, 
established that the main control of bilateral upper limb motor control is based 
on the dominant hemisphere [14] but in the current study the influence of 
hemisphere dominancy related to cortical thickness changes  was not directly 
tested as we did not have enough left handed subjects to compare dominant 
versus non dominant hemispheres.  
 
Against our expectation the primary motor cortex was surprisingly spared in 
both stroke groups. One possibility is that this absence of effect is due to 
methodological features of the voxel-based MRI analysis in which there could 
be some biases or errors in steps such as registration, segmentation and 
parcellation and area masking. Therefore an ROI analysis also performed, 
which would not suffer from all these potential biases, but it confirmed that 
there was no difference in MI thickness in the left hemispheric stroke group or 
the right hemispheric stroke group compared to the control group. Another 
possible factor can be some mild stroke cases, or in other words those with  
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better function, for instance who had Fugl-Meyer scores closer to 50 could 
have better hand movement than others so it could be the reason for no 
changes in M1 detected. Also another interpretation for this is that M1 
thickness varies substantially between patients, so that the patient groups as 
a whole do not differ from controls. 
 
There are some articles that investigated cortical thickness changes in 
different diseases. For instance, Janssen et al showed volumetric decreases 
of gyral and sulcal cortical structures in adolescents with first episode early-
onset psychosis [111] and another study in schizophrenia  patients showed 
greater cortical thinning in temporal-prefrontal cortex [99] and also in PTSD 
[112], but our findings are in stroke patients, which have not been tested in 
this way before. 
 
A particularly interesting result from this study was the negative correlation 
between M1 thicknesses on the side of stroke and volume of stroke, such that 
larger stroke volumes were associated with lower cortical thickness on the 
side of stroke. This suggests that the degree of secondary degeneration of 
motor cortex depends on the size of the original lesion. 
 
Schaechter et al studied structural plasticity in the somatosensory cortex in 
chronic stroke patients and showed a significant increase in somatosensory 
cortex after stroke [113] which could be related to compensation, but the 
current study showed cortical decrease after chronic stroke in motor areas 
and its correlation with stroke volume . 
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Healthy population 
 
This study also generated findings on patterns of cortical thickness in the 
healthy brain. In particular, the study demonstrated that there is symmetry in 
cortical thickness in all areas of the cortex. This means that there is no 
difference in cortical thicknesses of each cortical area between the left and 
right hemisphere in the normal population. By contrast, previous studies 
reported structural asymmetries in many areas of brain. For instance, it has 
been proved in the frontal lobe, that the right side is thicker than left side 
whereas in the occipital lobe also, the left side is thicker than  the right side 
[114].  
 
In addition, a generally higher cortical thickness in the left hemisphere has 
been reported [115]. It is  worthwhile mentioning that in previous studies 
subjects have been recruited between 18-44 years [114] or approximately 20 
– 30 years [115] which is different from our study, in which subjects were 30-
78 years, therefore the difference in result could be reasonable because of the 
higher range of ages. 
 
Previous studies of cortical thickness have focused on structural plasticity in 
the sensorimotor cortical areas that exhibit functional plasticity [113] or on sex 
and age differences in cortical thicknesses in healthy subjects [116] [115, 
117]. Studies of the effect of gender on cortical thickness showed thicker 
cortex in women on the posterior temporal and inferior parietal cortex and this 
effect is stable across the life span [116].  
 
From different studies it has been proven that the frontal cortex (near by 
primary motor cortex), premotor cortex, part of temporal cortex , 
parahippocampus and calcarine cortex (near to primary visual cortex) are the 
areas which degenerate more significantly by aging [88].  
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The effect of age on cortical thickness has also tested and a negative 
correlation has been found in most areas of both hemispheres between 
cortical thickness and age, with increasing age cortical thickness will 
decrease. This is consistent with previous studies, for example Preul et al. 
showed a significant decrease in cortical thickness in the same area  as this 
study with aging  [118]. 
 
In the current study the results show widespread cortical changes with aging 
in M1, part of the parietal cortex and the lingual cortex and the superior frontal 
and lingual cortex in both side of the brain and also a negative significant 
correlation in superior temporal cortex and isthmus cingulate cortex on the left 
side of brain and supramarginal cortex on the right side of brain. Table 4 
shows the significant areas with details. 
 
This difference can be interpreted by the difference of range of ages of 
subjects which was in a wide range (18-93 y) in the Salat study [88]   
 
Other possible discussion related to present study is that no difference was 
found between the male and female in cortical thicknesses, but previous 
studies showed some differences in cortical thickness regarding to gender. 
For instance, one study showed women have generally thicker cortex than 
men [118] and another study of age and brain volume in 18 men and women 
matched showed thicker cortex in temporal and parietal cortex in females 
[116].  
 
This difference could arise again because of the different method of analysis. 
They transformed the images into standard international consortium for brain 
mapping (ICBM) space [119] whereas we used MNI space. There was also a 
difference in number of subjects, which was 36 in the previous study [116] but 
we had 63 subjects which might provide greater sensitivity to change. 
Similarly, the range of age was 18-40 years in previous studies [118] but our 
study age range was two times more than the previous one, therefore this 
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greater variety of age in the present study could account for the different 
results.  
 
Previous imaging studies of cortical thickness have tended to test for effects of 
factors such as age and sex on thickness in the healthy population [116, 120, 
121] and none of the previous studies mentioned the cortical differences 
between two hemispheres in the normal population. 
 
A number of studies have tested effects of hand dominance by including left- 
or right-handed subjects [27, 122, 123]. However, Schaechter et al recruited 
10 cases for their study which all were right-handed except for one left-handed 
case [124]. This is similar to our study in which we had only three left-handed 
among 21 subjects. Therefore we were unable to test directly for effects of 
handedness but, given the small number of left-handed subjects hand 
dominance is not expected to have any major effect on the results.  
 
Functional measurements 
 
Some studies showed that functional tests are a valuable marker to measure 
recovery after stroke or recommended them as a clinical and research tool for 
evaluating changes in motor impairment following stroke such as the grip 
strength test and arm fugl meyer test [61, 62, 125, 126]. 
 
This study explored correlations between cortical thickness and functional 
tests. This study aimed to assess weather performance in such tests depends 
on stroke volume or on cortical degeneration, therefore, correlation of M1 
thickness and lesion size (stroke volume) tested which was between all left- 
and right-hemispheric stroke cases together versus the functional tests that 
assessed Neurological deficit and arm motor function included AMAT, AMFM, 
BBT and Grip strength Test. 
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The correlation between different functional behavioural tests and changes in 
M1 thicknesses and stroke volume was tested. As shown in the results 
chapter no significant correlation was found between different functional tests 
and stroke volume. This suggests that stroke volume does not contribute 
significantly to performance. It is likely that other factors, such as the location 
of the stroke, or the extent to which it damages specific structures, determine 
functional performance. As we know about data collecting standardization and 
sensitivity  people from one site travelled to each site and trained them on the 
clinical ratings for behavioural measures, and also for the imaging procedure 
each site performed a similar motor task and used somewhat similar anatomic 
protocols but not exact.  
 
In reviewing the literature, no data was found on the association between 
stroke volume in relation to cortical thickness and functional tests. Some 
studies have shown an association between damage to different levels of the 
corticofugal tract related to long-term hand motor recovery in one year post 
stroke patients or the importance of lesion location on upper limb motor 
recovery after stroke [127].However no previous study has attempted to relate 
changes in behavioural tests to cortical thickness changes following stroke. 
 
There are several possible explanations for the absence of correlations 
between behavioural test scores and thickness measures in the present study. 
Firstly to detect significant correlations with functional tests 21 cases might not 
be enough. Secondly, this type of stroke, which is lacunar, has a very small 
volume (although the effect on arm impairment is serious), so the variation in 
stroke volume is small and finally cortical thickness variation is also small. 
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Study limitations 
 
As this study aimed to analyse pre-existing imaging data there was no 
opportunity to change the original study design. In addition, some types of 
imaging data were not available. For instance It has been established that the 
thickness reductions have a linear relationship with initial hypoperfusion [128]. 
If there were acute DWI images or CT perfusion scans available for the 
patients studied in this thesis it could be tested whether the left hemispheric 
stroke patients have more severe hypoperfusion at the acute time than the 
right hemispheric stroke patients, so this could explain their greater grey 
matter reduction.  
 
The organization, from which we obtained data had some limitations to access 
patient images as patients were recruited around 5 years ago and from 3 
different centres with 3-T scanner all over the US and further data was 
impossible to access.  
 
Regarding the field strength, Hen et al found that the variability of local 
thickness measurement with 1.5 T and 3T is low and slightly biased[101], 
which was another concern of this study. All the analysis was done in one 
centre at FMRIB centre (Oxford Centre for Functional MRI of The brain) 
including brain registration, parcellation and all the other processes. 
 
The other data access limitation concerned the functional tests; there was not 
access to all subjects’ scores of Grip strength and there was some missing 
data which has been excluded in data analyses. So, this could cause some 
biases on the results because of the low number of the cases for functional 
tests. 
 
Finally, our control data was chosen from the OASIS database, thus the 
control group was not recruited at the same time as the patients, with identical 
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scanner or centres ,as it has mentioned previously it has been shown to have 
a negligible effect on the result [101]. 
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Chapter 8 – Conclusion 
 
 
The finding from this study suggests that the size of the lesion can be a 
predictor of further M1 cortex reduction. The correlation of M1 thickness with 
stroke volume showed that secondary cortical degeneration may be mainly 
driven by the size of axonal loss in capsular-striatal stroke. 
 
From normal subject study it can be concluded that generally cortical 
thickness will decrease by aging but gender does not have an effect on the 
cortical thickness. 
 
In addition, the lack of behavioural correlation with M1 thickness and stroke 
volume and also the non significant M1 cortex reduction versus control group 
may suggest that the long-term functional disability after capsular-striatal 
stroke may not be entirely dependent on primary motor cortex and secondary 
motor cortex and primary somatosensory cortex could have an important role 
as well. Further research in this area would be well advised to investigate the 
other cortical areas and with larger sample size. 
 
Further studies on the current topic are therefore recommended by using 
FMRI or DTI and checking the same hypothesis with those measurements. 
DTI is able to show the tracts that have been lost after stroke.  The lack of 
functionality of areas of brain can be assessed by FMRI. Furthermore a more 
thorough and complete behavioural functional test, including grip strength 
testing of all participants, is required. 
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Appendix 4: Descriptive analysis of cortical thickness. 
66 areas of brain is listed and specified by the side of stroke in brain as 
Ipsilesional and Contralesional. 
 
 
Areas 
N Mean 
Std. 
Deviation
Ipsilesional_caudalanteriorcingulate_Thickness 21 2.61419 .366026
Ipsilesional_caudalmiddlefrontal_Thickness 21 2.48586 .301934
Ipsilesional_corpuscallosum_Thickness 21 .05876 .128947
Ipsilesional_cuneus_Thickness 21 1.81710 .091526
Ipsilesional_entorhinal_Thickness 21 3.32671 .132611
Ipsilesional_fusiform_Thickness 21 2.61605 .365036
Ipsilesional_inferiorparietal_Thickness 21 2.46171 .180428
Ipsilesional_inferiortemporal_Thickness 21 2.76376 .113960
Ipsilesional_isthmuscingulate_Thickness 21 2.44610 .203208
Ipsilesional_lateraloccipital_Thickness 21 2.17576 .200523
Ipsilesional_lateralorbitofrontal_Thickness 21 2.50681 .148373
Ipsilesional_lingual_Thickness 21 1.96443 .148690
Ipsilesional_medialorbitofrontal_Thickness 21 2.39733 .147623
Ipsilesional_middletemporal_Thickness 21 2.80681 .205781
Ipsilesional_parahippo_Thickness 21 2.54981 .142932
Ipsilesional_paracentral_Thickness 21 2.32133 .256578
Ipsilesional_parsopercularis_Thickness 21 2.46043 .145898
Ipsilesional_parsorbitalis_Thickness 21 2.55624 .129122
Ipsilesional_parstriangularis_Thickness 21 2.38186 .215916
Ipsilesional_pericalcarine_Thickness 21 1.57281 .143345
Ipsilesional_postcentral_Thickness 21 2.11786 .160465
Ipsilesional_posteriorcingulate_Thickness 21 2.40400 .104449
Ipsilesional_precentral_Thickness 21 2.40248 .143366
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Ipsilesional_precuneus_Thickness 21 2.32205 .149833
Ipsilesional_rostralanteriorcingulate_Thickness 21 2.80952 .190225
Ipsilesional_rostralmiddlefrontal_Thickness 21 2.33871 .222656
Ipsilesional_superiorfrontal_Thickness 21 2.65871 .128613
Ipsilesional_superiorparietal_Thickness 21 2.23110 .148526
Ipsilesional_superiortemporal_Thickness 21 2.65114 .110076
Ipsilesional_supramarginal_Thickness 21 2.48657 .155321
Ipsilesional_frontalpole_Thickness 21 2.76981 .106099
Ipsilesional_Temporalpole_Thickness 21 3.54486 .236154
Ipsilesional_Transversetemporal_Thickness 21 2.28900 .336019
Contralesional_caudalanteriorcingulate_Thickness 21 2.49705 .232182
Contralesional_caudalmiddlefrontal_Thickness 21 2.54924 .203054
Contralesional_corpuscallosum_Thickness 21 .06429 .168258
Contralesional_cuneus_Thickness 21 1.86133 .021692
Contralesional_entorhinal_Thickness 21 3.30190 .158847
Contralesional_fusiform_Thickness 21 2.67495 .433546
Contralesional_inferiorparietal_Thickness 21 2.52267 .184897
Contralesional_inferiortemporal_Thickness 21 2.79286 .141161
Contralesional_isthmuscingulate_Thickness 21 2.51710 .248358
Contralesional_lateraloccipital_Thickness 21 2.26690 .237706
Contralesional_lateralorbitofrontal_Thickness 21 2.53124 .184920
Contralesional_lingual_Thickness 21 1.94581 .163232
Contralesional_medialorbitofrontal_Thickness 21 2.37005 .139480
Contralesional_middletemporal_Thickness 21 2.89010 .186151
Contralesional_parahippo_Thickness 21 2.61800 .170327
Contralesional_paracentral_Thickness 21 2.33895 .230117
Contralesional_parsopercularis_Thickness 21 2.49500 .165569
Contralesional_parsorbitalis_Thickness 21 2.58829 .176504
Contralesional_parstriangularis_Thickness 21 2.40629 .191727
Contralesional_pericalcarine_Thickness 21 1.54895 .148035
Contralesional_postcentral_Thickness 21 2.17933 .076138
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Contralesional_posteriorcingulate_Thickness 21 2.44348 .194405
Contralesional_precentral_Thickness 21 2.47862 .187049
Contralesional_precuneus_Thickness 21 2.34233 .167902
Contralesional_rostralanteriorcingulate_Thickness 21 2.74410 .196277
Contralesional_rostralmiddlefrontal_Thickness 21 2.34233 .212363
Contralesional_superiorfrontal_Thickness 21 2.67810 .150581
Contralesional_superiorparietal_Thickness 21 2.28367 .178553
Contralesional_superiortemporal_Thickness 21 2.72381 .146395
Contralesional_supramarginal_Thickness 21 2.56962 .118800
Contralesional_frontalpole_Thickness 21 2.70552 .128604
Contralesional_Temporalpole_Thickness 21 3.5403 .213237
Contralesional_Transversetemporal_Thickness 21 2.27052 .184170
 
 
Appendix 5: Calculation the volume of subcortical areas of 
brain. 
The volume of area is corrected regarding to the brain volume. 
Areas specified the side of stroke in brain as Ipsilesional and 
Contralesional. 
 
                      Areas N Mean Std. Deviation 
Ipsilesional_CerebralWhiteMatter 21 2.225E5 2.241E4 
Ipsilesional_CerebralCortex 21 2.358E5 1.772E4 
Ipsilesional_CerebellumWhiteMatter 21 1.606E4 3.425E3 
Ipsilesional_CerebellumCortex 21 4.800E4 7.283E3 
Ipsilesional_ThalamusProper 21 6.155E3 1.001E3 
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Ipsilesional_Caudate 21 3.901E3 7.646E2 
Ipsilesional_Putamen 21 4.815E3 7.690E2 
Ipsilesional_Pallidum 21 1.261E3 3.254E2 
Ipsilesional_Hippocampus 21 4.136E3 3.856E2 
Ipsilesional_Amygdala 21 1.679E3 2.552E2 
Ipsilesional_Accumbensarea 21 5.132E2 1.043E2 
Contralesional_CerebralWhiteMatter 21 2.270E5 1.960E4 
Contralesional_CerebralCortex 21 2.404E5 1.909E4 
Contralesional_CerebellumWhiteMatter 21 1.547E4 2.569E3 
Contralesional_CerebellumCortex 21 4.740E4 7.514E3 
Contralesional_ThalamusProper 21 6.618E3 8.012E2 
Contralesional_Caudate 21 3.753E3 5.129E2 
Contralesional_Putamen 21 5.082E3 5.100E2 
Contralesional_Pallidum 21 1.284E3 3.732E2 
Contralesional_Hippocampus 21 4.164E3 3.980E2 
Contralesiona;_Amygdala 21 1.701E3 1.453E2 
Contralesional_Accumbensarea 21 5.565E2 1.448E2 
Corpus callosum_Posterior 21 9.282E2 1.762E2 
Corpus callosum _Mid_Posterior 21 4.111E2 1.024E2 
Corpus callosum _Central 21 4.306E2 9.239E1 
Corpus callosum _Mid_Anterior 21 4.798E2 1.237E2 
Corpus callosum _Anterior 21 8.463E2 1.2663E2 
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Appendix 6: calculation of cortical volume of brain. 
Areas are specified by the side of stroke in brain as 
Ipsilesional and Contralesional. 
 
                       Areas N Mean Std. Deviation 
Ipsilesional_caudalanteriorcingulate_VOLUME 21 2.004E3 4.338E2 
Ipsilesional_caudalmiddlefrontal_VOLUME 21 6.160E3 1.165E3 
Ipsilesional_corpuscallosum_VOLUME 21 1.254E2 5.602E1 
Ipsilesional_cuneus_VOLUME 21 3.121E3 8.818E2 
Ipsilesional_entorhinal_VOLUME 21 1.716E3 3.596E2 
Ipsilesional_fusiform_VOLUME 21 8.639E3 1.394E3 
Ipsilesional_inferiorparietal_VOLUME 21 1.230E4 2.600E3 
Ipsilesional_inferiortemporal_VOLUME 21 1.002E4 1.914E3 
Ipsilesional_isthmuscingulate_VOLUME 21 2.124E3 4.720E2 
Ipsilesional_lateraloccipital_VOLUME 21 1.270E4 2.004E3 
Ipsilesional_lateralorbitofrontal_VOLUME 21 7.220E3 8.036E2 
Ipsilesional_lingual_VOLUME 21 6.667E3 1.139E3 
Ipsilesional_medialorbitofrontal_VOLUME 21 4.543E3 6.868E2 
Ipsilesional_middletemporal_VOLUME 21 1.093E4 2.103E3 
Ipsilesional_parahippocampal_VOLUME 21 1.850E3 3.072E2 
Ipsilesional_paracentral_VOLUME 21 3.468E3 6.146E2 
Ipsilesional_parsopercularis_VOLUME 21 4.164E3 1.310E3 
Ipsilesional_parsorbitalis_VOLUME 21 2.246E3 4.367E2 
Ipsilesional_parstriangularis_VOLUME 21 3.692E3 6.723E2 
Ipsilesional_pericalcarine_VOLUME 21 2.227E3 5.625E2 
Ipsilesional_postcentral_VOLUME 21 9.312E3 1.458E3 
Ipsilesional_posteriorcingulate_VOLUME 21 3.223E3 5.329E2 
Ipsilesional_precentral_VOLUME 21 1.256E4 1.618E3 
Ipsilesional_precuneus_VOLUME 21 8.949E3 1.807E3 
Ipsilesional_rostralanteriorcingulate_VOLUME 21 2.111E3 5.515E2 
Ipsilesional_rostralmiddlefrontal_VOLUME 21 1.487E4 1.805E3 
Ipsilesional_superiorfrontal_VOLUME 21 2.197E4 2.721E3 
Ipsilesional_superiorparietal_VOLUME 21 1.250E4 1.921E3 
Ipsilesional_superiortemporal_VOLUME 21 1.165E4 1.945E3 
Ipsilesional_supramarginal_VOLUME 21 9.483E3 1.444E3 
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Ipsilesional_frontalpole_VOLUME 21 
9.075E2 2.004E2 
Ipsilesional_temporalpole_VOLUME 21 2.364E3 3.737E2 
Ipsilesional_transversetemporal_VOLUME 21 1.034E3 2.954E2 
Contralesional_caudalanteriorcingulate_VOLUME 21 2.019E3 5.988E2 
Contralesional_caudalmiddlefrontal_VOLUME 21 6.376E3 1.412E3 
Contralesional_corpuscallosum_VOLUME 21 1.130E2 7.599E1 
Contralesional_cuneus_VOLUME 21 3.343E3 1.022E3 
Contralesional_entorhinal_VOLUME 21 1.815E3 3.954E2 
Contralesional_fusiform_VOLUME 21 8.500E3 1.520E3 
Contralesional_inferiorparietal_VOLUME 21 1.392E4 3.283E3 
Contralesional_inferiortemporal_VOLUME 21 9.846E3 2.320E3 
Contralesional_isthmuscingulate_VOLUME 21 1.976E3 3.217E2 
Contralesional_lateraloccipital_VOLUME 21 1.266E4 2.768E3 
Contralesional_lateralorbitofrontal_VOLUME 21 7.228E3 9.515E2 
Contralesional_lingual_VOLUME 21 6.490E3 1.367E3 
Contralesional_medialorbitofrontal_VOLUME 21 4.624E3 6.829E2 
Contralesional_middletemporal_VOLUME 21 1.160E4 1.708E3 
Contralesional_parahippocampal_VOLUME 21 1.941E3 5.083E2 
Contralesional_paracentral_VOLUME 21 3.890E3 9.374E2 
Contralesional_parsopercularis_VOLUME 21 3.981E3 9.139E2 
Contralesional_parsorbitalis_VOLUME 21 2.591E3 5.553E2 
Contralesional_parstriangularis_VOLUME 21 3.934E3 8.536E2 
Contralesional_pericalcarine_VOLUME 21 2.231E3 6.674E2 
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Contralesional_postcentral_VOLUME 21 1.002E4 1.923E3 
Contralesional_posteriorcingulate_VOLUME 21 3.324E3 7.497E2 
Contralesional_precentral_VOLUME 21 1.350E4 1.657E3 
Contralesional_precuneus_VOLUME 21 9.301E3 1.416E3 
Contralesional_rostralanteriorcingulate_VOLUME 21 2.042E3 6.834E2 
Contralesional_rostralmiddlefrontal_VOLUME 21 1.565E4 3.053E3 
Contralesional_superiorfrontal_VOLUME 21 2.206E4 2.397E3 
Contralesional_superiorparietal_VOLUME 21 1.257E4 1.942E3 
Contralesional_superiortemporal_VOLUME 21 1.158E4 1.289E3 
Contralesional_supramarginal_VOLUME 21 9.825E3 1.631E3 
Contralesional_frontalpole_VOLUME 21 8.925E2 1.868E2 
Contralesional_temporalpole_VOLUME 21 2.339E3 5.117E2 
Contralesional_transversetemporal_VOLUME 21 9.518E2 2.118E2 
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